Contact Us marketing@medicilon.com
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
SERVICES
SERVICES
01 Drug Discovery
Chemistry Research Biology Research Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates Active Pharmaceutical Ingredients Pharmaceutical preparation Analytical Method Development and Quality Control CMC Filings Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics Drug Safety Evaluation DMPK Bioanalysis IND Filings
PLATFORM
PLATFORM
01 One-stop Integrated Services
Liposome Drug Development Drug Discovery Pharmaceutical Research Preclinical Research Botanical Drug Preclinical R&D
02 Innovative Drug R&D Services
Peptide Drug Conjugate (PDC) Antibody Nucleic Acid Drug Cellular Immunotherapies mRNA Vaccine PROTAC ADC
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection Metabolite Identification (MetID) Drug Forming Research Flow Cytometry Technology SEND Format Conversion Flow Sorting NanoString nCounter Detection Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
Rodent Cerebrovascular Disease Inflammatory and Immune Diseases IO Pharmacodynamic Model
05 High-end Preparations Technology Platform
Skin Topical Preparation Ophthalmic drug Inhalation drug
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service KRAS-targeted Drugs R&D Service GLP-1 New Drug R&D Service
07 Safety Assessment Lab of Process Chemistry

08 Public Services
CAREERS
Talent Development
Campus Recruitment
Recruitment
NEWS
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
INVESTORS
Stock Information
Investment Contact
CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
CN
×
中
Close Button
Medicilon Events
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsMedicilon Events

Medicilon Events

Hot information：
Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division| Medicilon and Wuhan biolake successfully organized a biopharmaceutical salon| Medicilon FTE services & FFS services - flexible and efficient cooperation model
Dec 27,2019
Medicilon Assists Neupharma's RX108 to Enter Phase I Clinical Trials
​Recently, Suzhou Neupharma, an important partner of Shanghai Medicilon, announced that RX208 China phase I clinical research has completed the administration of the first patient in Shanghai Dongfang Hispital.
More
Medicilon Assists Neupharma's RX108 to Enter Phase I Clinical Trials
Dec 24,2019
Warmest Holiday Season Greeting From Medicilon 2020
Warmest Holiday Greetings to you and your families from Medicilon! As the end of year is approaching, we would like to express our sincere gratitude
More
Warmest Holiday Season Greeting From Medicilon 2020
Dec 19,2019
Medicilon assists Cgenetech to accelerate the development of new anti-diabetic drugs
On December 7, 2019, the 2019 annual meeting of the Biomedical Branch of the Shanghai European and American Alumni Association was held in Shanghai Pudong
More
Medicilon assists Cgenetech to accelerate the development of new anti-diabetic drugs
Dec 10,2019
Medicilon Co-organizes Shanghai European and American Alumni Association's Biomedicine Year-end Meeting
Recently, Medicilon's CMC preparations have developed another success. Amlodipine besylate tablets, a cardiovascular drug 289 base drug project developed for customers for lowering blood pressure,
More
Medicilon Co-organizes Shanghai European and American Alumni Association's Biomedicine Year-end Meeting
Nov 27,2019
Happy Thanksgiving 2019
Medicilon wishes you and your family a Happy Thanksgiving Day!
More
Happy Thanksgiving 2019
Nov 06,2019
Medicilon Inc. – Announcement of an IPO on Sci-Tech Innovation Board in China
Medicilon Inc. – Announcement of an IPO on Sci-Tech Innovation Board in China On Nov. 5th 2019, Shanghai Medicilon Inc. (Medicilon) announced an IPO on
More
Medicilon Inc. – Announcement of an IPO on Sci-Tech Innovation Board in China
Oct 29,2019
Insulin Technology Achieves a New Breakthrough, Medicilon Helps to Make a New Leap Forward!
Medicilon has currently completed the pharmacokinetic study of common insulin and oral insulin compound preparations of a company in Jiangsu, administered the test product subcutaneously and orally, and measured the blood glucose level of animals with a Roche blood glucose meter;
More
Insulin Technology Achieves a New Breakthrough, Medicilon Helps to Make a New Leap Forward!
Sep 27,2019
Medicilon will participate in SAPA-NJ Annual Conference 2019
sapa national conference 2019 SAPA-NJ Annual Conference will take place in Somerset, NJ on Sept 27-28, 2019.  Sino-American Pharmaceutical Professionals Association (SAPA) , founded in 1993,
More
Medicilon will participate in SAPA-NJ Annual Conference 2019
Sep 11,2019
Dr. Ma Jianguo: Adding "Green" to API Synthesis
I think the core concept of green chemistry is mainly reflected in three points: the first is security, the second is to reduce the "three wastes," and the third is to reduce costs. For more detailed explanations of green chemistry, refer to the "12 principles of green chemistry". This principle has explained a clear interpretation of the concepts and applications of green chemistry.
More
Dr. Ma Jianguo: Adding "Green" to API Synthesis
Sep 05,2019
Medicilon successfully exhibited in the ACS Meeting at San Diego
Medicilon successfully exhibit in the ACS Fall 2019 National Meeting which was held in San Diego on August 25-29.  Dr. Xingquan Ma, VP of Chemistry,
More
Medicilon successfully exhibited in the ACS Meeting at San Diego
Aug 30,2019
Medicilon's Differentiated Competitive Tactics Makes CRO Industry Chain "Small But Beautiful"
On August 27, 2019, the seminar on Preclinical Research of Innovative Drugs hosted by Shanghai Medicilon Inc. was successfully held in Beijing. 
More
Medicilon's Differentiated Competitive Tactics Makes CRO Industry Chain "Small But Beautiful"
Aug 29,2019
The Preclinical Research of Innovative Drug Seminar was successfully held in Beijing
On August 16-19, 2019, sponsored by the Chinese Pharmaceutical Association Drug Safety Evaluation and Research Committee, China Food and Drug Control Research Institute, Shanghai Medicilon
More
The Preclinical Research of Innovative Drug Seminar was successfully held in Beijing
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(781)535-1428(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->